Corbus Pharmaceuticals Holdings, Inc. is a clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of rare, chronic, and serious inflammatory and fibrotic diseases. Their leading product candidates include anti-inflammatory and anti-fibrotic therapies that target the endocannabinoid system, aiming to provide significant therapeutic benefits for patients with limited treatment […]
Read MoreJanux Therapeutics, Inc. (JANX) Janux Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr) platforms technology to treat patients suffering from cancer. Insmed Incorporated (INSM) Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases in the United […]
Read MoreSumitomo Mitsui Financial Group, Inc. (SMFG) Sumitomo Mitsui Financial Group, Inc., together with its subsidiaries, provides banking, leasing, securities, consumer finance, and other services in Japan, the Americas, Europe, the Middle East, Asia, and Oceania. Woori Financial Group Inc. (WF) Woori Financial Group Inc., together with its subsidiaries, operates as a commercial bank that provides a range […]
Read MoreMarket conditions are Bullish in a Bull Market as of 2024-07-16. This means traders and investors should consider trading with a Bullish bias by buying (going long) stocks, long ETF’s or Call Options. The rank of the Bull Market is 26.90 which indicates the current market conditions are Extreme, Risk of a reversal is high. […]
Read More